D-Histidine

D-Histidine is a naturally occurring D-amino acid featuring an imidazole side chain and a stereogenic alpha carbon, with a carboxylic acid and a primary amino group that define its zwitterionic character in aqueous media. The imidazole ring provides pH-dependent protonation states that participate in metal coordination, hydrogen bonding, and nucleophilic/electrophilic balance during derivatization. The D-configuration enables stereochemically defined incorporation into peptide frameworks and chiral synthetic sequences where mirror-image selectivity is required. As an amino acid intermediate, D-Histidine can be converted into protected amino acid derivatives, activated esters, or coupling-ready forms that support downstream peptide coupling and functional group transformation.

1. Peptide Synthesis

D-Histidine supports peptide building block preparation for solid-phase or solution-phase assembly where D-amino acid incorporation is used to control proteolytic stability and stereochemical recognition. The carboxyl and amino functionality can be protected and activated to enable amide bond formation, while the imidazole side chain can be selectively protected to prevent side reactions during coupling. D-Histidine-derived protected forms can be used to construct C-terminal and internal residues, including sequences that require defined imidazole orientation for receptor binding or enzyme-substrate mimicry. Resulting D-histidine-containing peptides and analogs serve as research materials for peptide science and as intermediates for peptidomimetic scaffold generation.

2. Chemical Biology

D-Histidine functions in chemical biology workflows that leverage the imidazole ring for pH-responsive behavior and coordination chemistry with transition metals. The D-stereochemistry can be used to probe stereospecific binding modes, enabling structure-activity relationship studies that compare L- versus D-histidine-containing motifs. Side-chain reactivity supports conjugation strategies such as derivatization through imidazole-directed coordination or orthogonally protected intermediate routes that maintain compatibility with other functional groups. Downstream products include labeled peptides, affinity probes, and biochemical research intermediates used to interrogate molecular recognition and enzyme active-site interactions.

3. Chiral Building Blocks

D-Histidine serves as a chiral amino acid intermediate for asymmetric synthesis planning and stereodefined construction of imidazole-bearing motifs. The stereogenic center and imidazole side chain enable controlled installation of functional groups at the alpha position while maintaining a defined side-chain identity for subsequent transformations. Protecting-group strategies for the amino and carboxyl groups, together with side-chain protection when required, facilitate stepwise synthesis of activated derivatives, chiral esters, or coupling partners used in peptide construction and medicinal chemistry intermediate preparation. The resulting chiral intermediates can be applied to fine chemical synthesis routes that require D-configured amino acid stereochemistry.

4. Side-Chain Functionalization

D-Histidine can be employed for side-chain functionalization and amino acid derivatization where the imidazole moiety acts as a handle for further chemical modification. Imidazole can participate in coordination to metals, undergo alkylation/arylation under controlled conditions, or be incorporated into heterocycle-forming sequences after appropriate protection and activation of the amino acid backbone. The amino acid framework supports conversion to N-protected derivatives and activated carboxyl derivatives that allow selective functional group transformations without disturbing the stereocenter. Downstream utility includes generation of imidazole-functional intermediates for peptidomimetics, enzyme inhibitors, and synthetic organic chemistry building blocks.

5. Analytical Research Standards

D-Histidine is suitable for analytical research as a stereochemically defined amino acid reference material in methods that distinguish D/L species and quantify imidazole-containing analytes. The combination of carboxylic acid, amino group, and imidazole side chain enables reliable derivatization and detection strategies for amino acid profiling in complex matrices. D-configuration supports method validation for chiral separation workflows and for monitoring amino acid transformations during synthesis or bioprocess development. Resulting analytical standards and calibration components can be used in quality control of peptide intermediates and in biochemical research where stereochemical integrity of amino acid residues matters.

6. Process Chemistry Intermediate

D-Histidine can be applied in process chemistry intermediate preparation for manufacturing routes that require D-amino acid building blocks with controlled protection and activation states. The functional group set supports conversion into N-protected amino acid derivatives and activated coupling forms that can be integrated into scalable peptide coupling operations and downstream purification workflows. Imidazole side-chain reactivity can be managed through appropriate protecting-group selection to reduce impurities from side reactions during manufacturing steps. Industrially relevant downstream outputs include D-histidine-containing peptide intermediates, specialty chemical intermediates, and fine chemical synthesis feedstocks that rely on stereochemically defined amino acid chemistry.

1. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

2. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

3. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment